Editorial Board Member - JHBD
Rammurti T. Kamble
Professor of MedicineBaylor College of Medicine
United States
BIOGRAPHY:
Dr. Rammurti T. Kamble is Professor of Medicine in Hematology-Oncology, Cell, and Gene Therapy, Baylor College of Medicine and Methodist Hospital, Houston, TX. He graduated from Ravi Shankar University, India in 1986 with a gold medal. He obtained postgraduate residency training from prestigious Postgraduate Institute of Medical Science and Research (PGIMER) Chandigarh, India and his fellowship training in Hematology-Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi. He was junior faculty in the AIIMS before joining MAMC, New Delhi University as Assistant Professor of Medicine. Between 1997 and 2001, he completed his residency and fellowship training in Internal Medicine and Hematology-Oncology from the University of Tennessee and the University of Arkansas for Medical Sciences respectively. He has served as Assistant Professor of Medicine and Associate Director of Hematology-Oncology fellowship program at Oklahoma University Health Sciences Center (OUHSC).
Dr. Rammurti T. Kamble has conferred Union against cancer (ICRETT, Geneva) award in 1994 to study molecular aspect of chronic myelogenous leukemia and bone marrow transplant in Hammersmith Hospital, London and Central Science and Industrial Research (CSIR) award in 1995 to study stem cell transplantation in Cornell University, New York. Dr. Kamble is board certified in Internal Medicine and Medical Oncology. He has published extensively in prestigious journals including, Blood, Biology of Bone marrow transplantation and Journal of Clinical Oncology and regularly reviews manuscripts for Blood, Biology of bone marrow transplantation and Bone marrow transplant.
RESEARCH INTERESTS:
Dr. Rammurti T. Kamble is primarily interested in hematologic malignancies including multiple myeloma and hematopoietic stem cell transplantation. His clinical interests are in innovative reduced conditioning protocols, in vivo T-cell depletion and novel approaches to reduce and treat graft-versus-host disease.
Other Editorial Board Members - JHBD
Luca Arcaini
Department of hematology
University of Pavia School of Medicine
Italy
Nejat Dalay
Istanbul University Oncology Institute
Turkey
Julie Teruya-Feldstein
Hematopathology
Immunohistochemistry Laboratory
United States
Yun Dai
Department of Medicine
Virginia Commonwealth University
United States
Francesco Passamonti
University Hospital Ospedale di Circolo
Fondazione Macchi, Varese
Italy
Salah Aref
Mansoura Faculty of Medicine
Mansoura University
Egypt
Andrew W. Taylor-Robinson
School of Medical & Applied Sciences
Central Queensland University
Australia
Jonathan Scott Harrison
Division of Hematology/Medical Oncology University of Missouri
United States
Saeid Abroun
School of Medicine
Tarbiat Modares University
Iran
Dan Douer
Memorial Sloan Kettering Cancer Center
New York
United States